Post-Transcriptional Gene Regulation of Inflammatory Genes in Steroid-Resistant COPD

Abstract

Due to the COVID pandemic, all research was paused at the University of Michigan in March 2020. It was re-started in stages in December 2020, at which time we applied for IRB approval. This delayed receiving IRB approval. As of June 4, 2021, we have received IRB approval from both the University of Michigan and Ann Arbor VA Healthcare System. To date, we have identified 440 participants (116 males and 323 females) who are interested in participating in the present study. The demographics of these individuals are listed in an attachment. We will start recruiting appropriate subjects from the different demographic groups and start sample collection. We started recruiting subjects after final IRB approval but had to stop in fall 2021 because of the COVID surge. All clinical studies were placed on hold at Ann Arbor VA Healthcare System. Clinical studies were re-started in spring 2022. These delays have resulted in significant delays in the project. We were granted a six month no-sot extension to continue the project.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
May 01, 2022
Accession Number
AD1177758

Entities

People

  • Ulus Atasoy

Organizations

  • University of Michigan

Tags

DTIC Thesaurus Topics

  • Biomedical Research
  • Carrier Proteins
  • Cells
  • Delivery Of Health Care
  • Department Of Defense
  • Gene Expression
  • Health Care
  • Health Services
  • Lung Diseases
  • Lymphocytes
  • Maryland
  • Medical Personnel
  • Michigan
  • Mrna
  • Regulations
  • Ribonucleic Acids
  • Universities

Fields of Study

  • Medicine

Readers

  • Academic Conference Management
  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Oncology and Biomarker-Based Cancer Detection.